Home > Publications database > DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers. > print

001     309939
005     20260220120944.0
024 7 _ |a 10.1007/s00066-026-02511-6
|2 doi
024 7 _ |a pmid:41701314
|2 pmid
024 7 _ |a 0179-7158
|2 ISSN
024 7 _ |a 1439-099X
|2 ISSN
037 _ _ |a DKFZ-2026-00388
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Schnellhardt, Sören
|0 0000-0003-0418-4401
|b 0
245 _ _ |a DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers.
260 _ _ |a Heidelberg
|c 2026
|b Springer Medizin
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1771510413_3004203
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #NCTZFB9# / epub
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Böke, Simon
|b 1
700 1 _ |a Tribius, Silke
|b 2
700 1 _ |a Krause, Mechthild
|0 P:(DE-He78)4be9ccb23f3e472b97743845cd2b3fe9
|b 3
|u dkfz
700 1 _ |a Haderlein, Marlen
|b 4
700 1 _ |a Rühle, Alexander
|b 5
700 1 _ |a Süß, Christoph
|b 6
700 1 _ |a Linge, Annett
|0 P:(DE-He78)81b719227985a27b1b77ed6766094319
|b 7
|u dkfz
700 1 _ |a Hecht, Markus
|b 8
700 1 _ |a Balermpas, Panagiotis
|b 9
700 1 _ |a Head
|b 10
700 1 _ |a DEGRO, Neck Cancer Expert Panel of the German Society of Radiation Oncology
|b 11
|e Collaboration Author
773 _ _ |a 10.1007/s00066-026-02511-6
|0 PERI:(DE-600)2003907-4
|p nn
|t Strahlentherapie und Onkologie
|v nn
|y 2026
|x 0179-7158
909 C O |o oai:inrepo02.dkfz.de:309939
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)4be9ccb23f3e472b97743845cd2b3fe9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)81b719227985a27b1b77ed6766094319
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2026
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-11-06
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-11-06
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-11-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-11-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-11-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-11-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-11-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-11-06
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-11-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-11-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-11-06
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b STRAHLENTHER ONKOL : 2022
|d 2025-11-06
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2025-11-06
920 1 _ |0 I:(DE-He78)DD04-20160331
|k DD04
|l Koordinierungsstelle NCT Dresden
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)DD04-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21